Navigation Links
CRN responds to JAMA fish oil study
Date:10/19/2010

WASHINGTON, D.C., October 19, 2010In response to a study regarding fish oil use during pregnancy published in the October 19 issue of the Journal of the American Medical Association (JAMA), the Council for Responsible Nutrition (CRN), the leading trade association for the dietary supplement industry, reminds pregnant and lactating women of the undisputed importance of consuming the recommended amounts of docosahexaenoic acid (DHA) throughout pregnancy. This can be done by eating two servings of fatty fish, such as sardines or anchovies, per week, or taking fish oil supplements (containing 200-300 mg/DHA, according to the Institute of Medicine) daily. While the benefits of DHA for a healthy pregnancy are well-established, more research is necessary to determine the effect of DHA on incidence of post-partum depression or neurocognitive development of infants.

"A large body of scientific evidence has established a strong relationship between the DHA status of mothers and infants and a variety of important pregnancy-related outcomes, including infant development," said Duffy MacKay, N.D., vice president, scientific & regulatory affairs, CRN. "Unfortunately in this trial, we have no idea of the DHA status of the mothers at the beginning of pregnancy or when they were evaluated for depression. Further we have no idea of the DHA status of the infants at 18 months when they were evaluated for neurocognitive outcomes. Without measurements of DHA status, it is difficult to draw conclusions from the study and certainly should not provide definitive advice to consumers."

There are many established variables that would impact individual DHA status for the mothers and children of both the supplemented and control group in this study, including differences in the ability to synthesize DHA from other fatty acids, the rate of maternal to fetal transfer of DHA, the status of other nutrients required to synthesize DHA, as well as other dietary sources of DHA not controlled for.

Dr. MacKay continued that the timeliness of the dosing may have had an impact. "Supplementation occurred from mid-term to deliverywe know that maternal DHA status returns to below pre-pregnancy levels within a few weeks from delivery. A mother in the treatment group who started the trial with low DHA status would have returned to pre-pregnancy status by the time she was evaluated for depression at six weeks and six months post delivery. We may have seen different results if these women took fish oil consistently leading up to, during and after pregnancy, or if we were able to stratify the results based on DHA status."

This applies to the findings for the infants, as well, as there is no information about what they were given in the eighteen month period following birthsome infants in the control group may have received DHA through breast milk if the mother was eating fish or taking fish oil supplements, or through DHA-enriched formula.

"Essentially, DHA status needs to be adequate throughout pregnancy for women and their infants to receive the many established benefits," continued Dr. MacKay. "We must also remember that both depression and childhood development are impacted by many different variables and maintaining good nutrition is just one important preventive step mothers can take to achieve the best outcomes. Taking fish oil has so many benefits; although this study did not prove that DHA dramatically impacted these complicated issues under these specific conditions, it's still widely known to be important for pregnant women and their offspring."

The DHA to Optimize Mother Infant Outcome (DOMInO) trial was conducted in five Australian maternity hospitals of 2,399 pregnant women who were less than 21 weeks' gestation to determine if taking fish oil provided 1) reduced risk of depressive symptoms in the postnatal period, and 2) improved developmental outcomes in the offspring.

Secondary study findings showed that the women supplemented with DHA had lower incidence of preterm birth and lower incidence of low birth weight offspring, which is associated with a variety of positive long-term outcomes, including better cognitive development. Aside from its heart benefits, fish oil is also important for mothers-to-be as it is known to reduce inflammation and promote brain, skin, bone and eye health.

"As the accompanying editorial acknowledges, taking fish oil can contribute to an overall healthy pregnancy. We encourage pregnant and lactating women, and all women of childbearing age to talk with their doctors and make sure they are receiving adequate amounts of DHA," said Dr. MacKay. "Additionally, these women should take 400 mcg of folic acid to help prevent neural tube birth defects. There are many things women can do to help optimize their health and wellness during pregnancyand at the end of the day all of this translates into better health for their baby."


'/>"/>

Contact: Erin Hlasney
ehlasney@crnusa.org
202-204-7684
Council for Responsible Nutrition
Source:Eurekalert

Related biology news :

1. New and unexpected mechanism identified how the brain responds to stress
2. Gene predicts how brain responds to fatigue, human study shows
3. Autism Speaks responds to recent publications citing autism clusters in California
4. New subtype of breast cancer responds to targeted drug
5. AMP responds to Genetic Test Registry request for information
6. Long-term study shows effect of climate change on animal diversity
7. £2 million study to reveal workings of dementia genes
8. New study looks to define evangelicals and how they affect polling
9. CU-Boulder study suggests air quality regulations miss key pollutants
10. Researchers study acoustic communication in deep-sea fish
11. Study reveals homeowner perceptions in fire-prone areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... published their findings on what they believe could be a new and helpful ... the new research. Click here to read it now. , Biomarkers ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
Breaking Biology Technology: